The CSL share price has been on a downward trajectory since the beginning of 2025, prompting investors to consider whether it's time to add this healthcare giant to their watchlist. As an expert analyst, I'll delve into the reasons why CSL shares might be worth considering, despite the recent price dip. From sticky revenue streams to the growing interest in ethical investing, there are several compelling factors at play here.
Sticky Revenue Streams: A Lifeline in Tough Times
One of the most intriguing aspects of healthcare investing is the stability of revenue streams. Unlike cyclical businesses that are susceptible to commodity price fluctuations or seasonal demand, healthcare companies benefit from essential spending. During economic downturns, people are less likely to cut back on healthcare, ensuring a consistent and 'sticky' revenue for these companies. This was evident during the Global Financial Crisis (GFC), where healthcare emerged as the best-performing sector.
Global Healthcare Spending: A Growing Pie
The global healthcare sector is experiencing significant growth, particularly in the United States, which accounts for over 40% of the global total. Projections indicate that US healthcare spending will grow at an impressive rate of 7% per year from 2022 to 2027, reaching a staggering US$819 billion. Within this broad sector, sub-sectors like healthcare IT, data solutions, and software-as-a-service (SaaS) companies are forecast to grow their revenue at an even more impressive rate of over 15% per year from 2024 to 2030. These growth prospects are hard to ignore for investors seeking substantial returns.
Ethical Investing: A Rising Trend
The rise of ethical and sustainable investing is another factor that positions healthcare companies favorably. A Morgan Stanley survey revealed that over half of investors plan to increase their allocation to sustainable investments in 2024. With growing interest in ethical practices, sectors like healthcare, which provide essential public services, are well-positioned to attract new capital and investors. This shift in investment trends could significantly impact the performance of healthcare companies, including CSL.
CSL Share Price: A Quick Read
To gauge the CSL share price, investors can examine metrics like dividend yield. While a high dividend yield might suggest growing dividends, it could also indicate a falling share price. In the case of CSL, the current dividend yield of around 3.21% is above its 5-year average of 1.50%. This could imply that dividends are growing, but it's essential to consider other valuation methods, such as Discounted Cash Flow (DCF) and Dividend Discount Models (DDM), which are available through free online courses and spreadsheets offered by Rask websites.
In conclusion, the CSL share price dip presents an opportunity for investors to consider adding this healthcare giant to their watchlist. With sticky revenue streams, global growth prospects, and the rising trend of ethical investing, CSL shares offer a compelling investment proposition. However, as with any investment decision, it's crucial to conduct thorough research and consider various valuation methods to make an informed choice.
